Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery: Letter to the editor

Mitesh Sharma; Rahul Nayar; Yitka  Graham; Helen M. Parretti; Sally Abbott; Abd Tahrani; Alexander D. Miras; Brijesh Madhok; Rishi Signal; Kamal Mahawar

doi:10.1007/s11695-022-06044-6

Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery: Letter to the editor

Mitesh Sharma (Lead Author), Rahul Nayar, Yitka Graham, Helen M. Parretti, Sally Abbott, Abd Tahrani, Alexander D. Miras, Brijesh Madhok, Rishi Signal, Kamal Mahawar

Research output: Contribution to journal › Comment/debate

3 Citations (Scopus)

9 Downloads (Pure)

Original language	English
Pages (from-to)	2469–2470
Number of pages	2
Journal	Obesity Surgery
Volume	32
Issue number	7
Early online date	28 Apr 2022
DOIs	https://doi.org/10.1007/s11695-022-06044-6
Publication status	Published - Jul 2022

Access to Document

10.1007/s11695-022-06044-6Licence: Unspecified

Final version manuscript letter to the editor 280322Accepted author manuscript, 39.2 KB

Cite this

Sharma, Mitesh ; Nayar, Rahul ; Graham, Yitka ; Parretti, Helen M. ; Abbott, Sally ; Tahrani, Abd ; Miras, Alexander D. ; Madhok, Brijesh ; Signal, Rishi ; Mahawar, Kamal. / Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery : Letter to the editor. In: Obesity Surgery. 2022 ; Vol. 32, No. 7. pp. 2469–2470.

@article{010efe20cb73424487b01a50b98cf7c5,

title = "Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery: Letter to the editor",

author = "Mitesh Sharma and Rahul Nayar and Yitka Graham and Parretti, {Helen M.} and Sally Abbott and Abd Tahrani and Miras, {Alexander D.} and Brijesh Madhok and Rishi Signal and Kamal Mahawar",

year = "2022",

month = jul,

doi = "10.1007/s11695-022-06044-6",

language = "English",

volume = "32",

pages = "2469–2470",

journal = "Obesity Surgery",

issn = "0960-8923",

publisher = "F D-COMMUNICATIONS INC",

number = "7",

}

Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery : Letter to the editor. / Sharma, Mitesh (Lead Author); Nayar, Rahul; Graham, Yitka ; Parretti, Helen M.; Abbott, Sally; Tahrani, Abd; Miras, Alexander D.; Madhok, Brijesh; Signal, Rishi; Mahawar, Kamal.

In: Obesity Surgery, Vol. 32, No. 7, 07.2022, p. 2469–2470.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery

T2 - Letter to the editor

AU - Sharma, Mitesh

AU - Nayar, Rahul

AU - Graham, Yitka

AU - Parretti, Helen M.

AU - Abbott, Sally

AU - Tahrani, Abd

AU - Miras, Alexander D.

AU - Madhok, Brijesh

AU - Signal, Rishi

AU - Mahawar, Kamal

PY - 2022/7

Y1 - 2022/7

UR - http://www.scopus.com/inward/record.url?scp=85129085829&partnerID=8YFLogxK

U2 - 10.1007/s11695-022-06044-6

DO - 10.1007/s11695-022-06044-6

M3 - Comment/debate

VL - 32

SP - 2469

EP - 2470

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 7

ER -

Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery: Letter to the editor

Access to Document

Other files and links

Cite this